Immune responsive resolvin D1 programs myocardial infarction‐induced cardiorenal syndrome in heart failure

Resolvins are innate, immune responsive, bioactive mediators generated after myocardial infarction (MI) to resolve inflammation. The MI‐induced bidirectional interaction between progressive left ventricle (LV) remodeling and kidney dysfunction is known to advance cardiorenal syndrome (CRS). Whether resolvins limit MI‐induced cardiorenal inflammation is unclear. Thus, to define the role of exogenous resolvin D (RvD)‐1 in post‐MI CRS, we subjected 8‐ to 12‐wk‐old male C57BL/6 mice to coronary artery ligation. RvD1 was injected 3 h after MI. MI mice with no treatment served as MI controls (d 1 and 5). Mice with no surgery served as naive controls. In the injected mice, RvD1 promoted neutrophil (CD11b+/Ly6G+) egress from the infarcted LV, compared with the MI control group at d 5, indicative of neutrophil clearance and thereby resolved inflammation. Further, RvD1‐injected mice showed higher reparative macrophages (F4/80+/Ly6Clow/CD206+) in the infarcted LV than did MI control mice at d 5 after MI. RvD1 suppressed the miRNA storm at d 1 and limited the MI‐induced edematous milieu in a remote area of the LV compared with the MI control at d 5 after MI. Also, RvD1 preserved the nephrin expression that was diffuse in the glomerular membrane at d 5 and 28 in MI controls, indicating renal injury. RvD1 attenuated MI‐induced renal inflammation, decreasing neutrophil gelatinase‐associated lipocalin and proinflammatory cytokines and chemokines in the kidney compared with the MI control. In summary, RvD1 clears MI‐induced inflammation by increasing resolving leukocytes and facilitates renoprotective mechanisms to limit CRS in acute and chronic heart failure.—Halade, G.V., Kain, V., Serhan, C.N. Immune responsive resolvin D1 programsmyocardial infarction‐induced cardiorenal syndrome in heart failure. FASEB J. 32, 3717–3729 (2018). www.fasebj.org

[1]  Ganesh V. Halade,et al.  Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology. , 2018, American journal of physiology. Heart and circulatory physiology.

[2]  Santosh A. Khedkar,et al.  Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing , 2017, Scientific Reports.

[3]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[4]  B. Tourki,et al.  Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  C. Serhan.  Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  S. Prabhu,et al.  Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction , 2016, Aging.

[7]  S. Prabhu,et al.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.

[8]  A. Orekhov,et al.  Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). , 2016, Journal of molecular and cellular cardiology.

[9]  D. Baltimore,et al.  MicroRNAs as regulatory elements in immune system logic , 2016, Nature Reviews Immunology.

[10]  S. Prabhu,et al.  Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation. , 2015, American journal of physiology. Heart and circulatory physiology.

[11]  Michael A. Lopez,et al.  Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy* , 2015, The Journal of Biological Chemistry.

[12]  W. Muller.  The regulation of transendothelial migration: new knowledge and new questions. , 2015, Cardiovascular research.

[13]  C. Serhan,et al.  Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. , 2015, Journal of molecular and cellular cardiology.

[14]  K. Damman,et al.  The kidney in heart failure: an update. , 2015, European heart journal.

[15]  M. Lindsey,et al.  Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction. , 2015, American journal of physiology. Heart and circulatory physiology.

[16]  Sumanth D. Prabhu,et al.  Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction , 2014, Basic Research in Cardiology.

[17]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[18]  E. Olson.  MicroRNAs as Therapeutic Targets and Biomarkers of Cardiovascular Disease , 2014, Science Translational Medicine.

[19]  D. Gilroy,et al.  Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. , 2014, Immunity.

[20]  C. Serhan,et al.  Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators. , 2013, Immunity.

[21]  M. Sekulic,et al.  A Compendium of Urinary Biomarkers Indicative of Glomerular Podocytopathy , 2013, Pathology research international.

[22]  Martin Reczko,et al.  DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..

[23]  A. Schober,et al.  The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1- and microRNA-155–Dependent Pathway During Atherosclerosis , 2013, Circulation.

[24]  J. Hensler,et al.  Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice , 2013, American journal of physiology. Heart and circulatory physiology.

[25]  P. Murray,et al.  A Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure , 2013, Cardiorenal Medicine.

[26]  Ira Tabas,et al.  Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013, Science.

[27]  D. Yellon,et al.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.

[28]  Andrew P. Voorhees,et al.  Matrix Metalloproteinase-28 Deletion Exacerbates Cardiac Dysfunction and Rupture After Myocardial Infarction in Mice by Inhibiting M2 Macrophage Activation , 2012, Circulation research.

[29]  YuanyuanWei,et al.  The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1- and microRNA-155–Dependent Pathway During Atherosclerosis , 2013 .

[30]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[31]  C. Serhan,et al.  Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation , 2012, Front. Immun..

[32]  M. Perretti,et al.  Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci: Receptor-Dependent Actions , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[33]  C. Serhan,et al.  Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. , 2012, The American journal of pathology.

[34]  K. Alexander,et al.  Short-Term Outcomes of Acute Myocardial Infarction in Patients With Acute Kidney Injury: A Report From the National Cardiovascular Data Registry , 2012, Circulation.

[35]  B. Klanke,et al.  Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage , 2011, Journal of hypertension.

[36]  Manuel T. Silva.  Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation , 2011, Journal of leukocyte biology.

[37]  Susan Cheng,et al.  Echocardiographic Speckle-Tracking Based Strain Imaging for Rapid Cardiovascular Phenotyping in Mice , 2011, Circulation research.

[38]  Sriram Krishnamoorthy,et al.  MicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuits , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  P. Ponikowski,et al.  Biomarkers in kidney and heart disease. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  C. Serhan,et al.  Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.

[41]  J. Cleland,et al.  Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH , 2002, European journal of heart failure.

[42]  Jeffrey M. Hausdorff,et al.  Neutrophilia and congestive heart failure after acute myocardial infarction. , 2000, American heart journal.